| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = -$2,345,598 ) |
| 2025 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U01HD109332 | A Dose Escalation Study of Low Dose Aspirin for the Prevention of Recurrent Preterm Birth | 000 | 1 | NIH | 11/6/2024 | $0 |
| 2025 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | T3242014 | NRSA for Primary Medical Care | 01 | 4 | HRSA | 10/4/2024 | $0 |
| 2025 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U3026936 | National Health Center Training and Technical Assistance Partners Cooperative Agreements (NTTAP) | 02 | 11 | HRSA | 10/10/2024 | $0 |
| 2025 | 2023 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U24HL140168 | 2/2: A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women | 000 | 6 | NIH | 10/1/2024 | -$304,355 |
| 2025 | 2023 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01MD018118 | Development of an Instrument for Assessment of Indigenous Historical Trauma as a Social Determinant of Health Among American Indian/Alaska Native Populations | 000 | 1 | NIH | 10/23/2024 | $0 |
| 2025 | 2023 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R21NS129478 | Development of NLRP3 inhibitors for HIV-associated neuroinflammation | 006 | 3 | NIH | 11/1/2024 | $88,875 |
| 2025 | 2023 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R21NS129478 | Development of NLRP3 inhibitors for HIV-associated neuroinflammation | 003 | 3 | NIH | 10/23/2024 | $156,884 |
| 2025 | 2022 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01CA222930 | Deregulation of COMPASS complex and enhancer chromatin in pancreatic cancer | 000 | 5 | NIH | 10/17/2024 | -$1,427 |
| 2025 | 2022 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R21AI157864 | Allogeneic cytotoxic gammadelta T cells for HIV cure immunotherapy | 000 | 2 | NIH | 10/30/2024 | $0 |
| 2025 | 2022 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | K23AR076505 | The role of IL-2 therapy for Relapsing-Remitting Chikungunya Arthritis | 000 | 3 | NIH | 10/10/2024 | -$19,769 |
| 2025 | 2022 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | K01MH118943 | A Multicomponent Intervention to Increase HIV Risk Perceptions and PrEPInitiation among Black Men Who Have Sex With Men | 000 | 4 | NIH | 10/22/2024 | -$3 |
| 2025 | 2022 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R21MH121313 | Developing and Validating New Measures of Multilevel Intersectional Stigma to Improve the HIV Prevention Continuum for Young Black Gay Bisexual and Other Men who Have Sex with Men in the South | 000 | 2 | NIH | 10/22/2024 | -$51,263 |
| 2025 | 2021 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U01DK048489 | 22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center | 005 | 28 | NIH | 10/1/2024 | -$3,718 |
| 2025 | 2021 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U01DK048489 | 22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center | 004 | 28 | NIH | 10/1/2024 | -$1,567 |
| 2025 | 2021 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U01DK048489 | 22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center | 003 | 28 | NIH | 10/1/2024 | -$57,035 |
| 2025 | 2021 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U01DK048489 | 22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center | 002 | 28 | NIH | 10/1/2024 | -$5,746 |
| 2025 | 2021 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U01DK048489 | 22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center | 001 | 28 | NIH | 10/1/2024 | -$9,194 |
| 2025 | 2021 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U01DK048489 | 22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center | 000 | 28 | NIH | 10/1/2024 | -$7,402 |
| 2025 | 2021 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U01DK048489 | 22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center | 006 | 28 | NIH | 10/18/2024 | $0 |
| 2025 | 2020 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U10HD036801 | Data Coord Ctr-NICHD Cooperative Multicenter Maternal Medicine Units Research Net | 000 | 22 | NIH | 10/1/2024 | -$2,074,364 |
| 2025 | 2019 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01DK104845 | Emotional Distress in a Comparative Effectiveness Trial of Diabetes Treatments | 000 | 5 | NIH | 10/1/2024 | -$55,514 |
|
| Issue Date FY: 2024 ( Subtotal = $89,942,398 ) (Continued on the next page) |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R25NR021373 | Advancing Social Determinants of Health Research through A CBPR Lens: A Short Course | 001 | 1 | NIH | 7/25/2024 | $234,489 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | T32AI158105 | Training in HIV Persistence, Co-morbidities and Therapeutics | 000 | 4 | NIH | 7/23/2024 | $201,776 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NR021169 | Implementation of an HIV Status-Neutral Nurse-Led Intervention to Increase Equity in Clinical Outcomes for Male HIV Self-Testers in Tanzania | 000 | 1 | NIH | 6/25/2024 | $783,348 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R21AI179423 | Defining HIV Env protein expression in latently infected cells | 000 | 2 | NIH | 7/19/2024 | $201,875 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01AI052056 | The functional significance of CTL escape | 001 | 22 | NIH | 5/16/2024 | $86,752 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | D43TW012206 | Trauma and Injury Research Training Program-Zambia | 000 | 4 | NIH | 8/16/2024 | $273,845 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NS124477 | Novel pathogenic mechanism of HIV-associated CNS neurological disorders | 001 | 4 | NIH | 6/21/2024 | $22,325 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U24HL166799 | 2/2 CORD-CHD: Clamp OR Delay among neonates with Congenital Heart Disease | 002 | 2 | NIH | 8/20/2024 | $54,433 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | T3242014 | NRSA for Primary Medical Care | 00 | 4 | HRSA | 7/2/2024 | $493,954 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R24AI152598 | The DC Cohort: A Longitudinal Population-Based Cohort Study of People Living with HIV in Washington, DC | 001 | 5 | NIH | 5/15/2024 | $4,667,321 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01HS028450 | Improving health data quality by assessing and enhancing semantic integrity | 000 | 3 | AHRQ | 5/10/2024 | $386,193 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R25AG081177 | Expanding the Pipeline to Graduate Research in Alzheimer's Disease and Related Dementias (EPGRAD) Program | 001 | 2 | NIH | 4/19/2024 | $0 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | T1641741 | MCH Pipeline Training Program | 00 | 4 | HRSA | 5/16/2024 | $150,110 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01DA054751 | Recreational Marijuana Marketing and Young Adult Consumer Behavior | 001 | 3 | NIH | 4/26/2024 | $87,442 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01CA247684 | Targeting Fanconi Anemia pathway to overcome platinum drug resistance in ovarian cancer | 001 | 4 | NIH | 4/17/2024 | $21,796 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01HL153154 | Effect of Hospital-Cardiologist Integration on Clinical Practice, Healthcare Quality, and Medicare Spending | 000 | 5 | NIH | 4/26/2024 | $559,871 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01AI153108 | CD4 dysfunction and cerebral toxoplasmosis | 000 | 4 | NIH | 5/13/2024 | $598,186 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01MH127767 | REstoring mental health after COVID-19 through commUnity-based Psychological services in New York City (RECOUP-NY) | 000 | 4 | NIH | 6/3/2024 | $703,625 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R21AI166279 | Dissecting the mechanism of pyrantel resistance in hookworm | 001 | 2 | NIH | 5/17/2024 | $20,187 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R61AI176582 | Ultrasensitive Env Detection Assay for Broadly Neutralizing Antibody Screening | 000 | 2 | NIH | 3/21/2024 | $449,464 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NS121608 | Development of Mass Spectrometry Strategies to Decipher Dynamic Lysosomal Dysfunctions in Frontotemporal Dementia | 001 | 4 | NIH | 4/10/2024 | $27,128 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NS124477 | Novel pathogenic mechanism of HIV-associated CNS neurological disorders | 000 | 4 | NIH | 5/8/2024 | $721,829 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01DK134311 | Regulation of prostate organogenesis by tissue-resident macrophages | 001 | 2 | NIH | 5/9/2024 | $21,318 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01CA270149 | Targeting lysine acetyltransferase MOF/KAT8 in lung cancer | 001 | 2 | NIH | 4/15/2024 | $18,576 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01CA275904 | Regulation of resistance to CDK4/6 inhibitor in breast cancer | 001 | 2 | NIH | 4/16/2024 | $31,698 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NS106244 | Thalamic contributions to the developing EEG | 001 | 6 | NIH | 4/5/2024 | $473,849 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U8126493 | Cooperative Agreement for a Regional Center for Health Workforce Studies | 01 | 12 | HRSA | 9/20/2024 | $5,000 |
|